Medical Education Library

Activating the Immune System to Treat Multiple Myeloma

This article was funded and directed by Bristol-Myers Squibb.

 

Sagar Lonial, MD

Chief Medical Officer, Winship Cancer Institute of Emory University

Chair, Dept. of Hematology and Medical Oncology, Emory School of Medicine

Faculty/Faculty Disclosure

Dr. Lonial reports that he is a compensated consultant for Bristol-Myers Squibb; Celgene Corporation; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Millennium Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; and Onyx Pharmaceuticals, Inc.

Click here to read the supplement

Recommended for You

News & Commentary

Quizzes from MD-IQ

Research Summaries from ClinicalEdge